Archive for the ‘Lyme’ Category

N.S. Mother Says Health-Care System Won’t Treat Her Daughter’s Lyme Disease

https://atlantic.ctvnews.ca/n-s-mother-says-health-care-system-won-t-treat-her-daughter-s-lyme-disease-

Category:

Activism, Lyme, Uncategorized

Lyme in Pregnancy: Associations With Parent & Offspring Health Outcomes – An International Cross-sectional Survey

https://www.frontiersin.org/articles/10.3389/fmed.2022.1022766/full

Front. Med., 03 November 2022
Sec. Infectious Diseases – Surveillance, Prevention and Treatment
https://doi.org/10.3389/fmed.2022.1022766

Lyme borreliosis in pregnancy and associations with parent and offspring health outcomes: An international cross-sectional survey

Katherine Leavey1, Rachel K. MacKenzie1, Sue Faber2, Vett K. Lloyd3, Charlotte Mao4,5, Melanie K. B. Wills6, Isabelle Boucoiran7,8, Elizabeth C. Cates1, Abeer Omar9, Olivia Marquez1 and Elizabeth K. Darling1*
  • 1McMaster Midwifery Research Centre, McMaster University, Hamilton, ON, Canada
  • 2LymeHope, Ontario, ON, Canada
  • 3Department of Biology, Mount Allison University, Sackville, NB, Canada
  • 4Dean Center for Tick Borne Illness, Spaulding Rehabilitation Hospital, Boston, MA, United States
  • 5Invisible International, Cambridge, MA, United States
  • 6G. Magnotta Lyme Disease Research Lab, Molecular and Cellular Biology, University of Guelph, Guelph, ON, Canada
  • 7Centre Hospitalier Universitaire (CHU) Sainte-Justine, Montréal, QC, Canada
  • 8Department of Obstetrics and Gynecology, Université de Montréal, Montréal, QC, Canada
  • 9Trent/Fleming School of Nursing, Trent University, Peterborough, ON, Canada

Background: Lyme disease (LD) is a complex tick-borne pathology caused by Borrelia burgdorferi sensu lato bacteria. Currently, there are limited data regarding the health outcomes of people infected during pregnancy, the potential for perinatal transmission to their fetus, and the long-term effects on these children. Therefore, the primary objective of this survey study was to investigate the impact of LD in pregnancy on both the parent and their offspring.

Methods: A seven-section survey was developed and administered in REDCap. Although recruitment was primarily through LD-focused organizations, participation was open to anyone over the age of 18 who had been pregnant. Participant health/symptoms were compared across those with “Diagnosed LD,” “Suspected LD,” or “No LD” at any time in their lives. The timing of LD events in the participants’ histories (tick bite, diagnosis, treatment start, etc.) were then utilized to classify the participants’ pregnancies into one of five groups: “Probable Treated LD,” “Probable Untreated LD,” “Possible Untreated LD,” “No Evidence of LD,” and “Unclear.”

Results: A total of 691 eligible people participated in the survey, of whom 65% had Diagnosed LD, 6% had Suspected LD, and 29% had No LD ever. Both the Diagnosed LD and Suspected LD groups indicated a high symptom burden (p < 0.01). Unfortunately, direct testing of fetal/newborn tissues for Borrelia burgdorferi only occurred following 3% of pregnancies at risk of transmission; positive/equivocal results were obtained in 14% of these cases. Pregnancies with No Evidence of LD experienced the fewest complications (p < 0.01) and were most likely to result in a live birth (p = 0.01) and limited short- and long-term offspring pathologies (p < 0.01). Within the LD-affected pregnancy groups, obtaining treatment did not decrease complications for the parent themselves but did ameliorate neonatal health status, with reduced rates of rashes, hypotonia, and respiratory distress (all p < 0.01). The impact of parent LD treatment on longer-term child outcomes was less clear.

Conclusion: Overall, this pioneering survey represents significant progress toward understanding the effects of LD on pregnancy and child health. A large prospective study of pregnant people with LD, combining consistent diagnostic testing, exhaustive assessment of fetal/newborn samples, and long-term offspring follow-up, is warranted.

________________

**Comment**

And that long-term offspring follow-up will never happen unless independent researchers take it upon themselves.  Our government just wants this to all go away – except for acute cases for which a lucrative “vaccine,” can be created, which is always viewed as a magic-bullet and will be a cash-cow with big profit margins.

The little we know about congenital Lyme has come primarily from Dr. Jones, RIP and a nurse who personally gathered all the research done on congenital Lyme disease out of the goodness of her heart and out of necessity for her own family.  This is typically how we finally get some answers, and frankly the best way to get real answers that are helpful.

Aren’t you tired of funding research with our tax dollars that doesn’t help patients?

For more:

Category:

Lyme, Pregnancy, research

COVID Shot Causing Uptick in Lyme Disease, EBV, CF

https://www.bitchute.com/video/EvVqpTtOtIGJ/  Video Here (approx. 8 Min)

Dr. Ryan Cole explains how the mRNA Shots are causing an uptick in Lyme disease, Epstein-Barr and chronic fatigue

Highlights:

  • COVID Shots are expired products designed for a virus strain no longer in circulation
  • The Spike Protein is causing reactivation of many viruses:
    • Epstein Barr
    • Other Herpes family viruses
      • Cytomegalovirus
      • CMV
    • Unusual viruses:
      • parechoviruses
      • parainfluenza viruses
  • There is an uptick in Lyme Disease due to immune suppression (go here and read comment section)
  • The COVID shots cause mitochondrial harm
  • The COVID shots cause heart damage
  • Sudden Adult Death syndrome (SADS) wasn’t happening in 2020 during the COVD outbreak, or in 2021 before the “vaccine” mandates. These deaths started occurring in late 2021 and have continued due to people  getting 3 and 4 shots.
  • The lipid nanoparticle accumulates in the ovaries.
    • Germany has seen a 20% decrease in early 2022 of fertility rates.  Similar things are seen in Sweden, Taiwan, and other Scandinavian countries.  While correlation doesn’t equal causation, this is concerning.
  • The spike protein has affected hormonal cycles.
  • The spike protein has affected the adrenal glands (blood pressure, cortisol, etc).
  • The spike protein inflames blood vessels and a lot of clotting has been seen.

_________________

https://rumble.com/v1pugsz-its-all-parasites-cancer-vaccines-remedies.html  Video Here (Approx. 35 Min)

COVID Shots, Parasites, & Cancer

Dr. Lee Merritt weighs in on the parasites in the COVID shots and the explosion of cancer.
Excellent information.  Highly recommend.  It connects many dots on the following information as well as 5G.

Egyptian parasitologists have linked cancer being caused by parasites for a long time; however, it’s never discussed as they will lose their funding.  Cancer cells and parasite egg sacks look identical under a microscope.

It’s been difficult if not impossible to know what is in the mRNA shots due to the fact “vaccine” manufacturers are not transparent about that is actually in the vials.  Researchers have had to simply speculate based on the symptoms that followed; however, leaked documents prove what many have suspected all along: the vials are all different.  The experimental mRNA shots, under emergency use authorization (EUA) are not approved, therefore, what the public is partaking in is an ongoing clinical study with numerous arms – i.e. people are given different doses and one group is getting a placebo group (should be an inert substance).  The last group falsely believes they are getting a “vaccine.”

But some have managed to get their hands on vials to study what’s in them:
  • German scientists, without exception, have found unusual toxic components, mostly metallic, in the shots.
  • Spanish researchers found that Pfizer’s shot consists of 99% graphene oxide, a known toxin that explodes the mitochondria causing an inflammatory storm that resembles COVID itself, conveniently mudding the waters once again making everything appear to be caused by COVID.
    • Graphene is also in the PCR swabs and in masks.
    • Graphene causes hypercoagulation which causes blood clotting.
    • Graphene is a superconductor which gives a metallic taste, loss of taste and smell, and the magnetic phenomenon of being able to put a spoon on your body and have it stick.
    • In an interview with Dr. Mylo Canderian, Ph.D., developer of the graphene oxide patent as a hematological bioweapon in 2015, states those “vaccinated” with the COVID shots will all die within a maximum window of 10 years.
  • Swissmedic discovered bubbles in vials.
  • Microscopy expert Dr. Robert Young also shows that COVID vials contain graphene oxide, parasites (Trypanosoma Cruzi), stainless steel, and other metals and contents.  Please read here to learn that parasites manipulate the immune system to establish infection – often chronically and that a third of the human population may be affected.  Coinfections often hinder accurate diagnosis.
  • Dr. Carrie Madej observed graphene type substances as well as a self-aware moving substance that looks and acts like “Hydra Vulgaris.”
  • Korea Veritas Doctors for COVID 19 have also observed “moving organism.”

Dr. Merrit recommends the following anti-parasitic treatment approach:

  • Use anti-parasitics for 3 days then stop for 5 days.
  • Gradually lengthen your cycle (use for 3 days stop for 10 and so on), watching for a reaction.
  • Do this for a minimum of 2 months for an adult.
  • When you can go to monthly cycles you are on maintenance.

I also highly recommend this video with Dr. Merrit as well.

For more:

Category:

Activism, Lyme, vaccines, Viruses

Penile Cancer After a Tick Bite: A Possible Association

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323426/

 2021; 9: 2050313X211036779.
Published online 2021 Jul 28. doi: 10.1177/2050313X211036779
PMCID: PMC8323426
PMID: 34377488

Penile cancer after a tick bite: A possible association

Ognen Ivanovski,1 Skender Saidi,1 Bashkim Shabani,1 Slobodan Gurmeshevski,1 Risto Pejkov,1 Selim Komina,2 and Aleksandra Gavrilovska-Brazanov3
Author information Article notes Copyright and License information Disclaimer

Abstract

Penile cancer is a rare cancer in Western countries, but is more common in parts of the developing world. Usually, it is associated with older uncircumcised men who have a long-term phymotic preputium. Here, we report a case of penile cancer in a circumcised patient, occurring 3 months after a tick bite on the head of the penis. To the best of our knowledge, this is the first report that suggests a possible association between Lyme disease and occurrence of “de novo” penile cancer. Further studies are needed to confirm this hypothesis.

_______________

**Comment**

Other research has implicated tick-borne illness with cancer, as well as the COVID shots.

And these studies will never happen because Fauci, the highest paid government employee who owns numerous patents, is the gatekeeper of immunosuppression diseases. What’s important about this is that if immunosuppression diseases actually exist, vaccines become obsolete. Mafia overlord, Fauci can not allow the truth to come out because our government owns over 50 patents on vaccines, and NIH owns half of the Moderna COVID shot.  There’s simply too much at stake.

Fauci, head of NIAID for 7 presidencies, is also the controller of the purse strings for government research grants and researchers know they must tout the accepted narrative if they want funding. He would rather fund lucrative, but horrifically grizzly experiments on children and puppies – and of course big cash cows like mRNA products and “vaccines,” that our corrupt public health agencies own patents on and receive secret payments from.  It’s a win-win for government and Big Pharma while the public suffers in silence.

For more:

Ticks manage to get everywhere.

Category:

Lyme, research, Ticks, Transmission

Low Dose Naltrexone for Chronic Pain

https://www.paintreatmentdirectory.com/posts/low-dose-naltrexone-for-chronic-pain

Low Dose Naltrexone for Chronic Pain

Low Dose Naltrexone for Chronic Pain

By: Chris Graf

11/7/22

Low doses of a drug that is commonly prescribed to recovering alcoholics and narcotic addicts is being used to help chronic pain sufferers find relief from a variety of pain conditions including fibromyalgia, inflammatory bowel, Crohn’s disease, and complex regional pain syndrome.  The drug is called naltrexone.

What is naltrexone?

Naltrexone is a prescription medication used to suppress narcotic and alcohol cravings in recovering addicts. Naltrexone is used as just one part of an addict’s overall treatment plan. It is prescribed only after a person is no longer dependent on drugs or alcohol.

How does Naltrexone work?

Naltrexone blocks the euphoric sensations associated with narcotic and alcohol use. It is non-addictive and produces no narcotic-like effects.

Researchers believe that naltrexone also modulates the release of inflammatory chemicals in the central nervous system. The drug temporarily binds to and blocks the Mu opioid receptors (MORs) which are central to pain control. When these receptors are blocked, the body responds by producing more pain-relieving endorphins.

Dosage of naltrexone for addiction vs for pain relief

When used for the management of addiction, the typical daily dosage of naltrexone is 50–100 mg per day. For chronic pain relief, the dosage is typically less than 8 mg per day. Patients may start off with a dose as low as .01 mg. A more typical starting dose is 1.5 mg. On average, dosages of low-dose naltrexone (LDN) are approximately 1/10th of the typical addiction treatment dosage.

Prescriptions for LDN can be filled by compounding pharmacies that grind up the higher dose tablet into ultra-low doses.

Are there side effects of naltrexone?

Common side effects of naltrexone when used for addiction management include nausea, fatigue, and loss of appetite. While most side effects are mild, serious side effects are possible. The Mayo Clinic provides a comprehensive list of all possible side effects. Side effects are less likely to occur in patients taking low doses of the drug.

A 2014 review found that the use of LDN for pain relief was “well tolerated” by patients and that there was “low reported incidence of adverse side effects.”

Research on low-dose naltrexone for pain relief

  • Results of a review conducted in 2014 indicated that “Low-dose naltrexone (LDN) has been demonstrated to reduce symptom severity in conditions such as fibromyalgia, Crohn’s disease, multiple sclerosis, and complex regional pain syndrome.” The review found Crohn’s disease to be the condition with the most scientific support when it comes to the efficacy of LDN for pain relief.
  •  A 2018 review found that “Clinical reports of LDN have demonstrated possible benefits in diseases such as fibromyalgia, Crohn’s disease, multiple sclerosis, complex-regional pain syndrome, Hailey-Hailey disease, and cancer.”
  • According to a 2020 review, “Low-dose naltrexone (LDN) has shown promise to reduce symptoms related to chronic pain conditions such as fibromyalgia, inflammatory bowel conditions, and multiple sclerosis.”
  • A systematic review conducted by the University of Michigan School of Dentistry concluded that “Low-dose naltrexone provides an alternative in medical management of chronic pain disorders as a novel anti-inflammatory and immunomodulator. It can offer additional management options, as orofacial pain conditions share characteristics with other chronic pain disorders.” Authors of the study consider the drug “a good option for patients with orofacial and chronic pain, without the risk of addiction.”

What pain management specialists say about LDN

According to an article published by Weill Cornell Medicine in September 2020, their pain management specialists have had success treating chronic pain patients with low-dose naltrexone. When interviewed, Dr. Neel Mehta, said, “Generally, my patients report pain relief greater than 50 percent, that they’re sleeping better, or can return to work. And some patients end up responding well to doses as low as 0.1 for reasons we don’t yet completely understand. Patients are experiencing good results with low harm in these early studies.”

In an article published by NPR, Dr. Bruce Vroorman, an associate professor at Dartmouth’s Geisel School of Medicine and the author of the above-mentioned 2018 review, was interviewed. According to the article, “Vrooman says that when it comes to treating some patients with complex chronic pain, low-dose naltrexone appears to be more effective and well-tolerated than the big-name opioids that dominated pain management for decades.” He said that LDN is a “game changer” for some chronic pain patients.

In an interview with Michigan News, orofacial pain specialist Elizabeth Hatfield discussed the use of LDN. She said, “We found a reduction in pain intensity and improvement in quality of life, and a reduction in opioid use for patients with chronic pain.” She went on to say that it is best used on centralized pain disorders including fibromyalgia, complex regional pain syndrome, and TMJ.

Low-dose naltrexone may be a possible treatment for long COVID

According to a recent article published by Reuters, Dr. Jack Lambert, an infectious disease expert at University College Dublin School of Medicine, ran a pilot study on the use of LDN for long COVID. Lambert has reported previous success in using LDN to treat pain and fatigue associated with chronic Lyme disease.

After being treated with LDN for two months, the 38 pilot study participants reported improvement in energy, pain, concentration, insomnia and overall recovery from COVID-19.

Lambert is preparing to run a larger trial to confirm the results. He believes it is possible that LDN may work to repair the damage done to the body by the virus. 

Conclusion

Low-dose naltrexone appears to be safer and more effective for chronic pain than widely used opioids. It might be worth a try if you’re in chronic pain and want to avoid, reduce or eliminate the use of opioids. It’s important to find a knowledgeable healthcare provider who can guide you in terms of dosages and how to taper off of opioids safely.

Other options that involve oral administration of a substance in order to avoid, reduce or eliminate the use of opioids while safely improving pain relief include marijuana, CBD, kratom, an anti-inflammatory diet, nutritional supplements including vitamin D and magnesium.

Find an Alternative Pain Treatment Provider Near You

Find Natural Pain Relief Products

Christine Graf is a freelance writer who lives in Ballston Lake, New York. She is a regular contributor to several publications and has written extensively about health, mental health, and entrepreneurship.  

For more:

Category:

Lyme, Pain Management, research, Treatment, Viruses